ITOS

iTeos Therapeutics (ITOS)

About iTeos Therapeutics (ITOS)

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.

Details

Daily high

$8.32

Daily low

$8.16

Price at open

$8.21

52 Week High

$18.13

52 Week Low

$4.80

Market cap

314.6M

Dividend yield

0.00%

Volume

365,404

Avg. volume

1.7M

P/E ratio

-2.55

iTeos Therapeutics News